What is EdenRx and what does it offer?

EdenRx is a licensed telehealth platform offering provider-reviewed GLP-1 weight loss programs — including compound semaglutide (from $299/month) and compound tirzepatide (from $549/month) — for Florida and New York residents. No clinic visits required. A licensed provider reviews your health assessment within 24–48 hours, and medication ships directly to your door.

What are GLP-1 medications and how do they work?

GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone to suppress appetite, slow gastric emptying, and regulate blood sugar. Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are the most clinically proven GLP-1 medications, producing 15–22% average body weight loss in clinical trials.

How much does semaglutide cost in Florida?

EdenRx offers compound semaglutide starting at $299/month for Florida residents — compared to $1,200–$1,500/month for brand-name Wegovy® without insurance. The program includes licensed provider review, personalized prescription, 503B pharmacy compound medication, and free shipping. No insurance required. Only pay if approved.

How much does tirzepatide cost in New York?

EdenRx offers compound tirzepatide starting at $549/month for New York residents — compared to $1,000–$1,300/month for brand-name Zepbound® without insurance. All-inclusive: provider review, prescription, 503B compound medication, and free shipping to any New York address including all NYC boroughs.

Do I need to visit a clinic for GLP-1 treatment?

No. EdenRx is 100% online. Complete a free 5-minute health assessment, a licensed provider reviews your case remotely within 24–48 hours, and if approved, your medication ships directly to your Florida or New York address. No in-person visits or appointments required.

How much weight can I lose with semaglutide or tirzepatide?

Clinical trial data: semaglutide produces an average of 14.9% body weight loss over 68 weeks (STEP-1 trial, NEJM 2021). Tirzepatide produces up to 20.9% average body weight loss over 72 weeks (SURMOUNT-1 trial, NEJM 2022). For a 200-lb patient: ~30 lbs (semaglutide) to ~42 lbs (tirzepatide). Individual results vary.

What is compound semaglutide vs Ozempic or Wegovy?

Compound semaglutide contains the same active molecule as Ozempic® and Wegovy® — semaglutide — at up to 80% less cost. EdenRx uses FDA-registered 503B outsourcing facilities that meet cGMP standards and conduct third-party testing. Compound semaglutide: from $299/month vs. Wegovy® at $1,200–$1,500/month.

Who qualifies for GLP-1 weight loss treatment?

You may qualify if you have a BMI ≥ 30 (obesity), or a BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma, pancreatitis, or MEN2 syndrome. Complete EdenRx's free assessment to find out if you qualify.

Is EdenRx available in New York City?

Yes. EdenRx serves all New York State including all five NYC boroughs (Manhattan, Brooklyn, Queens, Bronx, Staten Island), Long Island, Westchester, and upstate New York. Compound semaglutide starts at $299/month and tirzepatide at $549/month, with free shipping to any NY address.

What is the best Ozempic or Wegovy alternative?

Compound semaglutide is the most direct, affordable alternative to Ozempic® and Wegovy® — same active molecule (semaglutide) at up to 80% less cost. EdenRx offers compound semaglutide from $299/month vs. $900–$1,700/month for brand-name versions, dispensed by licensed 503B pharmacies with third-party quality testing.

How does EdenRx review patient assessments?

Every patient assessment is personally reviewed by a licensed provider in Florida or New York. No prescriptions are issued automatically. Clinical review of health history, contraindications, and eligibility criteria is required before any treatment is offered.

How does EdenRx protect patient data?

All patient health data is HIPAA-compliant, encrypted in transit and at rest, and never sold or shared with third parties without explicit consent.

Who can access my health information at EdenRx?

Only your assigned licensed provider and authorized clinical staff have access to your health information, on a minimum-necessary basis. Access is logged and audited.

Clinical Standards

Our Standards

How EdenRx reviews patients, protects health data, fulfills prescriptions, and makes clinical decisions — explained clearly, without jargon.

Clinical ReviewData PrivacyPatient-First DecisionsEligibility-Based CarePharmacy StandardsOngoing Care

Clinical Review Process

Every patient assessment is personally reviewed by a licensed provider — not processed automatically
Providers evaluate eligibility based on BMI, medical history, contraindications, and clinical criteria
Patients who do not meet eligibility criteria are not prescribed treatment
Providers may request additional information before making a final decision
All prescriptions require an active patient-provider relationship as required by applicable telehealth law
Medical Director oversight ensures all protocols meet applicable standards of care

Data Privacy Approach

All health information is HIPAA-compliant and encrypted in transit and at rest
Patient data is never sold to third parties, advertisers, or data brokers
Access to health records is restricted to assigned providers and authorized clinical staff
All access is logged and regularly audited
You may request deletion of your data in accordance with applicable privacy law
Our platform uses role-based access controls to enforce minimum-necessary data access

Patient-First Decisions

No payment is required before provider review — assessment is always free
Treatment is only offered when a licensed provider determines it is medically appropriate
Patients are never pressured to select a specific plan or medication
Dose adjustments and treatment modifications are provider-directed, not automated
Patients may cancel treatment at any time per our cancellation policy
Provider messaging is available for clinical questions throughout the treatment relationship

Eligibility-Based Care

Eligibility is evaluated individually — not every patient qualifies
Medical contraindications are actively screened at intake (thyroid history, pancreatitis, eating disorder history, and others)
State availability is strictly limited to states where our providers hold active medical licenses
Patients who are not eligible receive a clear explanation and recommended next steps
Re-evaluation is available if medical circumstances change
No treatment is offered to patients who do not meet clinical criteria

Pharmacy Fulfillment Standards

All medications are dispensed by licensed U.S. pharmacies — no overseas or gray-market suppliers
Pharmacy selection is based on patient location, medication availability, and provider determination
Compounding pharmacies used by EdenRx are licensed under federal and state regulations
Compound medications are distinct from FDA-approved brand-name equivalents — this is disclosed to all patients
Medications are shipped in compliant, properly labeled packaging
Cold-chain shipping protocols are used when clinically required

Ongoing Care Standards

All active patients have access to secure provider messaging for clinical questions
Provider check-ins are conducted at intervals appropriate to each plan
Refills require provider review before each renewal cycle
Dose adjustments are based on provider assessment of patient progress and tolerability
Patients experiencing side effects are directed to contact their provider through the secure portal
Emergency situations are referred to 911 or appropriate emergency services

EdenRx operates as a telehealth platform connecting patients to licensed providers in Florida and New York. Compound medications dispensed through EdenRx are not FDA-approved under the same NDA as brand-name equivalents. All treatments require provider evaluation and approval. Results vary. Not all patients qualify. For medical emergencies, call 911 immediately.